AAOS Now, August 2019
-
Study Identifies Outcome Predictors for FAIS Hip Arthroscopy
A study presented at the American Orthopaedic Society for Sports Medicine Annual Meeting in Boston detailed the use of a predictive model for achieving the minimal clinically important difference (MCID) in patients undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS).
-
Gabapentin Reduces Opioid Use after Foot and Ankle Surgery
A study presented at the American Orthopaedic Foot & Ankle Society Specialty Day during the AAOS 2019 Annual Meeting found that in patients who had foot and ankle surgery, acute postoperative pain was significantly better among those receiving gabapentin compared to those who were not. By two weeks post-surgery, those taking gabapentin required less opioids for postoperative pain than those who did not receive gabapentin.
-
Study Illustrates Self-reported Low Pain Tolerance Linked to Increased Opioid Consumption after Foot and Ankle Surgery
Patients who viewed themselves as having a low pain threshold took more opioid medication after foot and ankle surgery than those with a high self-reported pain threshold, according to a study presented at the American Orthopaedic Foot & Ankle Society Specialty Day during the AAOS 2019 Annual Meeting. Daniel Fuchs, MD, of the Rothman Institute, presented the study, which was a retrospective follow-up of a prospective cohort study (Saini et al., 2018).
-
Taking Joint Replacement to the Outpatient Setting: AAOS Course Sets You on the Right Track
On Oct. 18, AAOS will host a new single-day course, “AAOS Outpatient and Rapid Recovery in Total Joint Replacement,” which will address the increasing demand for same-day discharge after total joint replacement (TJR). Expert faculty will provide tips for safely implementing an outpatient rapid recovery program in your own institution or practice.